Ryman rights trading ends on a sour note

Ryman rights trading ends on a sour note
Salt Funds' Matt Goodson said time will tell whether Ryman shares are cheap. (Image: Salt Funds)
Jenny Ruth
Ryman Healthcare’s $902 million rights issue is drawing to a dismal close, with the price of the rights falling as low as 7.5 cents on Tuesday, the last day of trading.Two weeks ago, in the institutional book-build auction process, institutional investors were prepared to pay an effective $1 for the rights.You could say that was a little disappointing because the theoretical value of the rights price was $1.03 – institutions paid $6 for the shares issued at $5, so the additional price paid reflected the value they put on the rights....

More Finance

Jarden: reassuring to see a more 'bullish' horticulture outlook
Finance

Jarden: reassuring to see a more 'bullish' horticulture outlook

Scales has had a tough year but there are signs of new growth. 

BoP council considers Tauranga port stake sale
Finance

BoP council considers Tauranga port stake sale

The council holds its stake through Quayside Holdings.

Fonterra fattens margins when its farmers are getting squeezed
Finance

Fonterra fattens margins when its farmers are getting squeezed

The co-op released its quarter one results on Thursday.

Riley Kennedy 08 Dec 2023